Smith Kevin Raymond Merrill bought INGN
December 1, 2025 · Form 4 insider transaction
Smith Kevin Raymond Merrill bought 28,334 shares of Inogen, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
28,334
Price
$0.00
Total value
N/A
InsiderSmith Kevin Raymond Merrill
RoleOfficer, Director
CompanyInogen, Inc. (INGN)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 1, 2025
Filing dateDecember 2, 2025
Shares owned after100,108
OwnershipDirect
10b5-1 planNo
AmendedNo